Abstract Introduction. The importance of non-agents accounted for renal function impairment in nearly 30% of patients. insulin-dependent diabetes mellitus (type II diabetes) as a leading cause of end-stage renal disease is now Conclusion. Our observational study illustrates the high burden of cardiovascular diseases contrasting with widely recognized. The purpose of this study was to assess life-prognosis and its predictors in a cohort of sub-optimal cardiovascular therapeutic interventions in type II diabetes patients entering dialysis. Factors patients newly entering dialysis. Material and methods. Eighty-four consecutive type II aggravating renal failure were mainly iatrogenic, and therefore largely avoidable. Late referral generally diabetes patients (40% of all patients) starting dialysis between 01/01/95 and 31/12/96 were studied retrospect-implied a poor clinical condition at the start of dialysis. ively, focusing on clinical data at inception and lifeprognosis after a mean follow-up of 211 days. Patients Key words: acute renal failure; chronic renal failure; were divided into three groups, according to onset of diabetes; diabetic nephropathy; dialysis; mortality; type renal failure: acute 11% (9/84), chronic 61% (51/84) II diabetes and acutely aggravated chronic renal failure 28% (25/84). Results. Patients (mean age 67 years) had longstanding diabetes (mean duration~15 years), heavy Introduction proteinuria (~3 g/24 h) and diabetic retinopathy (67%). The average creatinine clearance (Cockcroft's According to various registry reports ( USRD, EDTA) formula) was 13 ml/min. Cardiovascular diseases were [1,2] the proportion of diabetic patients among the highly prevalent at the start of dialysis: history of patients entering dialysis is increasing continuously. In myocardial infarction (26%), angina (36%) and acute the US and some other regions, diabetic nephropathy left ventricular dysfunction (67%). More than 80% of is now recognized as the most common cause of endthe patients underwent the first session dialysis under stage renal disease ( ESRD): the proportion of diabetic emergency conditions, a situation in part related to patients newly admitted for dialysis was 35.3% in 1994 late referral to the nephrology division (63% for in the US, 42% in Germany during the same year and chronic patients). A great majority of the patients were 15% in France [3] [4] [5] . overhydrated when starting dialysis, as evidenced by These patients experience high mortality and morthe average weight loss of 6 kg, during the first month bidity, mainly cardiovascular, during the first years of of dialysis, required to reach dry weight. Nearly 64% dialysis treatment (and probably in earlier stages of of the patients presented high blood pressure uraemia before dialysis also). This high mortality-(>140/90 mmHg) when starting dialysis despite anti-morbidity rate is generally attributed to co-morbidhypertensive therapy (mean: 2.3 drugs). The outcome ity especially from cardiovascular causes, but may of this type II diabetes population was dramatic: 32% also result from other factors such as inadequate (27/84) died after a mean follow-up of 211 days, cardiovascular therapy or late referral. mostly from cardiovascular diseases. The rate of recovWe report our experience in a cohort of 84 consecutery of renal function was low in both the acute and ive type II diabetes patients entering dialysis in a single the acutely aggravated renal failure group (30% and centre in Strasbourg (France). Our renal division is 24%, respectively). Of note, iatrogenic nephrotoxic unusual in that it deals with both chronic and acute renal failure (except in those patients requiring artificial respiratory support for long periods) and 'covers'
criteria 1985 and 8.1% according to recent ADA criof at least 50% at T1 compared with T0; (iii) patients with teria [6 ] . Diabetes represents 40% of patients entering chronic renal failure (CRF ), i.e. patients with a creatinine dialysis in our centre compared with 15.69% (87% type clearance below or equal to 20 ml/min or patients with II diabetes) in other centres of 'France metropoli-creatinine clearance between 20 and 60 ml/min at T0 and a taine' [7] . rise in creatinine plasma concentration of less than 50% at T1 compared with T0.
The average follow-up of the whole group was 211 days
Material and methods
(range 1-722). In the ARF group the mean follow-up was 45 days, compared with 134 days in the ACRF group and 262 days in the CRF group. In this retrospective study we included all consecutive type II diabetes patients starting dialysis in a single centre ( University Hospital of Strasbourg), between 1 January 1995 Statistical analysis and 31 December 1996. This cohort included 84 patients, representing 40% of all patients who had undergone at least Results were expressed as mean±SD unless stated otherwise. one haemodialysis session during this period in our centre.
Comparisons of means between groups were carried out The study included a few patients with acute kidney failure using ANOVA for multiple groups followed by post hoc who required dialysis treatment at least once. The great tests when necessary. Comparison of frequency was permajority were patients with chronic ESRD who started formed by x2 test. Survival analysis was made according to maintenance dialysis therapy. Emergency extra-renal therapy the Kaplan-Meier analysis of cumulated survival rate. was performed by haemodialysis. Later, both modalities of Differences were considered significant for P values <0.05. extra-renal therapy were considered; so, among the 84 patients included in the study, 17 (20%) were finally treated by peritoneal dialysis and 67 (80%) by haemodialysis.
Results
The diagnosis of type II diabetes was based on the medical history, confirmed by the following standard criteria [8]: Patients characteristics (Table 1) diabetes diagnosed after the age of 30 years; no insulin treatment during the first 3 months after diagnosis; no history The 84 type II diabetes patients included in our study of keto-acidosis. Those patients whose diabetes was disco-were divided into the three groups, as described above: vered at the beginning of dialysis (n=2) were considered to (i) nine patients (11%) with acute renal failure (ARF ); have type II diabetes in view of their ages of 58 and 67 years, (ii) 25 patients (30%) with acute on chronic renal respectively. Patients with type 1 diabetes, representing only failure (ACRF ); (iii) 50 patients (59%) with chronic 4.5% (4/88) of all the diabetic patients starting dialysis, were renal failure (CRF ).
excluded from our study.
The mean age of patients was 67±10 years and the (Table 2) disease (PVD) was retained on the basis of 'hard' criteria, i.e. patients presenting severe arteriopathy with at least one The main features of co-morbid conditions are sumdistal amputation not due to trauma. marized in Table 2 . Briefly, only 25% of all patients We distinguished three categories of patients based on the (21/84) failed to have a history of cardiac problems.
mode of onset of renal failure. Plasma creatinine concentration and creatinine clearance calculated according to
Clinical and laboratory features at the onset of
Cockcroft's formula [9] [10] [11] were assessed at two different
extra-renal therapy for ESRD (Tables 3 and 4)
moments: the start of dialysis (T1) and the last known determination of the creatinine plasma concentration (gener-The average glomerular filtration rate (GFR) estimated ally 3-12 months before) (T0). The groups were defined as from the calculated creatinine clearance at the time of follows: (i) patients with acute renal failure (ARF ), i.e. all starting dialysis was 13±12 ml/min. patients having a creatinine clearance above or equal to Fifty-four patients (64%) presented with hyperten-60 ml/min at T0; (ii) patients presenting with an acute sion (>140/90 mmHg) when entering the dialysis proaggravation of pre-existing chronic renal failure (ACRF ), i.e. patients with a creatinine clearance between 20 and gramme. In 16 patients (19% of total ) systolic blood No statistical differences between groups; ARF, patient with acute renal failure; ACRF, patient with acute-on-chronic renal failure; CRF, patient with chronic renal failure. pressure was above 180 mmHg and/or diastolic blood Circumstances of the first dialysis treatment (Table 5 ) pressure above 100 mmHg. In the group with ARF In only 16% of the patients was the first dialysis session 67% of patients had no hypertension, conversely, 84% planned and scheduled (among them, 25% of the CRF of the CRF patients presented hypertension. patients). Almost 90% of both ARF and ACRF Eighty-three per cent of the patients were on antihy-patients had to be treated under emergency conditions, pertensive medication, including 94% of the CRF compared with 73% in the CRF group. The type of group; the average number of anti-hypertensive drugs emergency comprised hyperkalaemia, acute left ventriwas 2.3±1 per patient. Despite the high prevalence of cular dysfunction, anuria, severe acidosis, pericarditis, cardiovascular disease, fewer than 10% received a beta-severe uraemia (seven patients with a mean blood urea blocker and only 23% were treated with angiotensin of 56.2 mmol/l ). Hyperkalaemia [mean blood K: converting enzyme inhibitors (ACEI ); 25% were 6.24 mmol/l (n=13)] was present in 15% of all patients and 44% of the patients of the ARF group. Pulmonary treated with aspirin. oedema was the most frequent indication necessitating ively. Among patients with ARF and ACRF, almost 50% (15/34) of all insults to renal function occurred immediate dialysis, it was present in 42% of patients during a preceding hospitalization. compared with only 22% in the ARF group.
Among patients with ARF or ACRF, nine were The mean difference between the body weight of the treated with ACEI. In four of these patients, the patient at the onset of dialysis therapy and 1 month combination ACEI+aminoglycosides (n=1), ACEI+ later was~5.8 kg, representing~8% of the initial non-steroidal anti-inflammatory drugs (n=2) and weight.
ACEI+contrast agents (n=1) may have further promoted the loss of renal function. Factors aggravating the renal course (Table 6) Administration of radiocontrast was found in 14% Based on medical records, we identified factors which of the population. The proportion was higher among could potentially explain the terminal loss of renal patients with ACRF (28%). Administration of nephrofunction necessitating the start of dialysis: radio-toxic agents was noted in 6% of all patients and 22% contrast, nephrotoxic agents (aminoglycosides, non-of patients with ARF, respectively. steroidal anti-inflammatory drugs), urinary tract Cardiac failure as an aggravating factor was found obstruction, cardiac failure and cardiac surgery. These in 14% of patients with CRF. One patient with ARF factors were detected in half the study population, i.e. and one with ACRF had a history of recent cardiac in all patients with ARF, in 68% of patients with surgery.
Urinary tract obstruction was found in 6% of all ACRF and in only 33% of patients with CRF, respect- ARF, patient with acute renal failure; ACRF, patient with acute-on-chronic renal failure, CRF: patient with chronic renal failure. patients, and in 11 and 12% of patients with ARF and Discussion ACRF respectively. The factors responsible for the deterioration of renal Our study reports on a large cohort of 84 type II function were reno-vascular disease (occlusion of the diabetes patients starting haemodialysis in a single main renal artery), and myeloma in one case each. In French renal centre. As a result, evaluation and care 50% of cases no evidence of aggravating factors was were fairly homogeneous for all patients. This 'non found.
profit' centre is the only one in an area with almost one million inhabitants, so that recruitment bias can Main outcomes (Table 7 ) (Figure 1) be reasonably excluded. The aim of the present study was to evaluate clinical features at inception of dialysis Concerning the outcome of renal failure, 18% of the therapy and consecutive morbidity during early followpatients regained sufficient renal function to allow up. Patients were characterized according to the mode discontinuation of dialysis. As expected more patients of onset of terminal renal failure (acute, acute-onwith ARF and ACRF recovered renal function (30% chronic, chronic). and 24%, respectively, compared with 12% of patients The mean age of our patients was 67 years. There with CRF ). Half of the patients were still on dialysis was no significant difference in age between the three at the end of the study period, i.e. 61% of patients different modes of onset. Most of the patients had with CRF, 36% of patients with ACRF and 22% of both long-standing diabetes and chronic renal failure patients with ARF.
with heavy proteinuria. The mean duration of diabetes The overall mortality in the study population at the at the start of dialysis was 15 years (range 0-50 years), end of the follow-up was 32%. As expected, survival similar to that described in other studies [12] [13] [14] . We among patients who failed to recover was significantly admit that the diagnosis of diabetic nephropathy could better in patients with CRF (67%) compared with not be definitely ascertained in view of the lack of patients with ACRF or ARF (44% and 22% respectrenal evaluation before starting dialysis. In a small ively, P<0.05). No significant difference of outcome group of 10 patients who had undergone a renal biopsy was found with respect to the modality of extra-renal before entering dialysis, only 6/10 showed typical histotherapy (peritoneal dialysis vs haemodialysis). Indelogical features of diabetic nephropathy. In type II pendent predictors of mortality in the Cox regression diabetes some studies have reported a prevalence of model were age, ARF vs CRF (relative risk 11.17; CI up to 16-40% of renal diseases unrelated to diabetes 95%: 2.35-53.07) and the use of contrast medium [3, 5, [15] [16] [17] . (relative risk 4.76; CI 95%: 1.58-14.28).
As shown in Table 2 , we found a high burden of comorbid conditions in this population, especially with regard to cardiovascular diseases. This heavy comorbidity present at the start of dialysis had a great influence on survival. In the subgroup of patients with a history of coronary heart disease (myocardial infarction and symptomatic angina) or acute left ventricular failure, mortality was 55% (10/18) for a mean followup of 305 days. A history of peripheral vascular disease with amputation increased mortality to 70% (7/10 patients) for a mean follow-up of 214 days. The adverse prognostic value of coronary heart disease, left ventricular failure or peripheral vascular disease has also been underlined by several reports on dialysis patients with or without diabetes [4, 13, [17] [18] [19] . patients had persisting high blood pressure. We especi-
